The effect of radiologic imaging studies on the risk of secondary malignancy development in patients with Hodgkin lymphoma

Clinical Lymphoma and Myeloma

Volumn 7, Issue 7, 2007, Pages 467-469

  Beyan, Cengiz ^a   Kaptan, Kürşat ^a   Ifran, Ahmet ^a   Öcal, Ramazan ^a   Ulutin, Cüneyt ^a   Öztürk, Bekir ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Computed tomography; Diagnostic imaging; Ionizing; Positron emission tomography; Radiation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FOLLOW UP; HODGKIN DISEASE; HUMAN; IONIZING RADIATION; MALE; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RISK ASSESSMENT;

EID: 34548724446     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2007.n.028     Document Type: Article

References (16)

1. D'Sa S, Abildgaard N, Tighe J, et al. Guidelines for the use of imaging in the management of myeloma. Available at: http://www.bcshguidelines.com/pdf/ Management_of_Myeloma_2006.pdf. Accessed November 8, 2006.
2. Harris NL. Hodgkin's lymphomas: classification, diagnosis, and grading. Semin Hematol 1999; 36:220-232.
3. Hart D, Wall BF. Radiation exposure of the UK population from medical and dental x-ray examinations. National Radiological Protection Board. Available at: http://www.hpa.org.uk/radiation/publications/w_series_reports/2002/nrpb_w4. htm. Accessed March 15, 2002.
4. Semelka RC. Imaging X-rays cause cancer: a call to action for caregivers and patients. Available at: http://www.medscape.com/viewprogram/5063?rss. Accessed February 13, 2006.
5. Health risks from exposure to low levels of ionizing radiation: BEIR VII-Phase 2. 2005. Available at: http://books.nap.edu/catalog/11340.html. Accessed February 1, 2006.
6. Brenner D, Elliston C, Hall E, et al. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001; 176:289-296.
7. Brenner DJ. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatr Radiol 2002; 32:228-233.
8. Hancock SL, Hoppe RT. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol 1996; 6:225-242.
9. Valagussa P, Santoro A, Fossati-Bellani F, et al. Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 1986; 4:830-837.
10. van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, et al. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 1994; 12:1063-1073.
11. Swerdlow AJ, Douglas AJ, Hudson GV, et al. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 1992; 304:1137-1143.
12. Boivin JF, Hutchison GB, Zauber AG, et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995; 87:732-741.
13. Salloum E, Doria R, Schubert W, et al. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 1996; 14:2435-2443.
14. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 1994; 12:312-325.
15. Yahalom J, Petrek JA, Biddinger PW, et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992; 10:1674-1681.
16. Kumar R, Maillard I, Schuster SJ, et al. Utility of fluorodeoxyglucose- PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 2004; 42:1083-1100.